<DOC>
	<DOCNO>NCT01509703</DOCNO>
	<brief_summary>The aim study gain knowledge effect high flow transnasal insufflation various breathe parameter like intratracheal pressure condition , CO2 elimination , breathe frequency tidal volume .</brief_summary>
	<brief_title>Respiratory Physiology Under High Flow Therapy</brief_title>
	<detailed_description>Ten patient , supply tracheostomy stent ( placeholder ) reinsertions long term ventilation treat short time day nasal high flow system AIRVO different flow rate ( 15 , 30 , 45L/min ) estimate possible long term implication high flow treatment . Respiration measure impedance plethysmography calibrate belt system ( Respitrace , VIASYS ) . Pressure end tidal CO2 concentration measure inside placeholder . The order high flow rate ( 15 , 30 , 45L/min ) randomize ; flow rate measure 15 minute . A wash time ten minute plan phase . In time patient breathes individual oxygen flow rate attention oxygen saturation , exceed 96 % . Transcutaneous PCO2 SpO2 monitor TOSCA study .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Patients stable wean phase long term ventilation Patients supply tracheostomy stent ( placeholder ) Patients stable respiratory situation Incapable give consent Any severe acute physical illness require intensive medical care</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>COPD</keyword>
	<keyword>Nasal High Flow Therapy</keyword>
	<keyword>tracheotomy stent</keyword>
	<keyword>tracheotomy</keyword>
</DOC>